US equities |
NVDA $241.03 ▲+0.89% SPCX $173.35 ▲+1.32% MU $1,065.69 ▲+0.16% AMD $656.69 ▲+3.95% MRVL $283.39 ▲+4.48% SNDK $1,673.65 ▼-1.79% AVGO $378.11 ▲+4.30% INTC $113.30 ▼-2.49%
FinancialContent

Latest News about Structure Therapeutics Inc

Recent news which mentions Structure Therapeutics Inc

Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags Business News Breaking News: Business Roche Holding AG
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Biotechnology Biotech and Pharmaceuticals AstraZeneca PLC
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Biotechnology Biotech and Pharmaceuticals Business
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Health care industry Structure Therapeutics Inc Health & Science
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Zealand Pharma A/S Altimmune Inc Science
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Breaking news Pfizer Inc Companies
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Business News Weight management Roche Holding AG
From CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
Tags Business News Biotech and Pharmaceuticals Biotechnology
From CNBC.com News